FNY Managed Accounts’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
Other funds holding RARE
BFA
CWAM
BIT
FNY Managed Accounts's RARE Position: Q4 2016 in Review
FNY Managed Accounts sold out of Ultragenyx Pharmaceutical (RARE) in Q4 2016, closing a stake of 50 shares — an estimated $3.55K sold.
FNY Managed Accounts first reported a position in RARE in Q1 2016 and held it in 2 quarters. The position peaked at $63.3K in Q1 2016. 174 funds tracked by Wall St. Rank hold RARE as of Q4 2016.
- FNY Managed Accounts reported no remaining Ultragenyx Pharmaceutical position as of Q4 2016 after selling out during the quarter.
- FNY Managed Accounts sold 50 Ultragenyx Pharmaceutical shares in Q4 2016, an estimated $3.55K.
- FNY Managed Accounts first reported a position in Ultragenyx Pharmaceutical in Q1 2016 and held it in 2 quarters.
- FNY Managed Accounts's Ultragenyx Pharmaceutical position peaked at $63.3K in Q1 2016.
- 174 funds tracked by Wall St. Rank held Ultragenyx Pharmaceutical as of Q4 2016.
Based on FNY Managed Accounts's 13F filing for Q4 2016, filed 8 Feb 2017.